Samuel V Angiuoli

Title: Innovations of Samuel V Angiuoli

Introduction

Samuel V Angiuoli is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of molecular diagnostics, holding two patents that showcase his expertise and innovative spirit. His work focuses on improving the quality and performance of diagnostic methods, particularly in the realm of cancer detection.

Latest Patents

Angiuoli's latest patents include "Qualification of sequencing instruments and reagents for use in molecular diagnostic methods." This patent presents techniques for qualifying, checking, and monitoring the use of diagnostic apparatuses and reagents, such as sequencing apparatuses and reagents, to ensure performance and quality of diagnostic methods. The system described in this patent includes a memory configured to store identifiers of sequencing apparatuses and their associated status, a network interface for communication, and a processor that determines whether a sequencing run is designated as a qualification run.

Another significant patent is "Machine learning system and method for somatic mutation discovery." This invention provides a machine learning system and method that enhances the identification of tumor-specific mutations. The improved identification of these mutations can significantly impact the discovery of alterations and the therapeutic management of cancer patients.

Career Highlights

Samuel V Angiuoli is currently employed at Personal Genome Diagnostics, Inc., where he continues to innovate in the field of molecular diagnostics. His work is instrumental in advancing the capabilities of diagnostic tools and methodologies.

Collaborations

Angiuoli collaborates with talented professionals in his field, including Derrick Wood and David Riley. Their combined expertise contributes to the success of their projects and the advancement of molecular diagnostics.

Conclusion

Samuel V Angiuoli's contributions to molecular diagnostics through his innovative patents demonstrate his commitment to improving healthcare outcomes. His work continues to influence the field and pave the way for future advancements in cancer detection and management.